SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018694
Filing Date
2016-05-10
Accepted
2016-05-09 18:47:53
Documents
46
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20160331.htm 10-Q 1422554
2 EX-10.1 rare-ex101_11.htm EX-10.1 31744
3 EX-10.2 rare-ex102_9.htm EX-10.2 31488
4 EX-10.3 rare-ex103_8.htm EX-10.3 47555
5 EX-31.1 rare-ex311_7.htm EX-31.1 17410
6 EX-31.2 rare-ex312_10.htm EX-31.2 17489
7 EX-32.1 rare-ex321_6.htm EX-32.1 10793
8 GRAPHIC ggkhqklt1ram000001.jpg GRAPHIC 43395
  Complete submission text file 0001564590-16-018694.txt   4029494

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT rare-20160331.xml EX-101.INS 802825
10 XBRL TAXONOMY EXTENSION SCHEMA rare-20160331.xsd EX-101.SCH 23597
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20160331_cal.xml EX-101.CAL 30451
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20160331_def.xml EX-101.DEF 48797
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20160331_lab.xml EX-101.LAB 167382
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20160331_pre.xml EX-101.PRE 118519
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 161633175
SIC: 2834 Pharmaceutical Preparations